Trial Profile
Study on bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Testosterone
- Indications Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 20 Jun 2007 New trial record.